RE: RE: RE: RE: Drought: The bad and the good Simply, this company can not survive by spending $12 million a year in R&D, and then $14 million a year in Sales & Marketting while revenues are not growing exponentially. Yes the company business model has a lot of leverage but that only means something as revenues are growing, which they are not.
Time to think the business and consider how to reward the long term investors.
Oh, by the way, I'm sure Steven Koles and the rest of management won't be crying too hard after a soft Q3 and Q4, since the share price will linger and thus they will get some cheaply priced stock options! A big win for them, a huge failure for investors.
Time for the BOD to establish a new set of rules for stock options for executives.